ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Tevogen Bio Secures Funding from Team of Doctors to Support Clinical Trials of Its Investigational Curative T Cell Therapy for COVID-19 prnewswire
January 26, 2021Tevogen Bio announced it has secured necessary funding from HMP Partners of New Jersey, an investment firm managed by medical doctors, which will allow Tevogen to support all clinical trials of its investigational, potentially curative COVID-19 treatment. -
Li Ka-shing Announced His Retirement, but His “Pharmaceutical Empire” is just Starting
Yuntian
March 30, 2018Li Ka-shing officially announced his retirement at a press conference recently, which has aroused wide attention from China and outside China.
Pharma Sources Insight July 2025
